These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 409089)

  • 1. Effect of stimulation of dopaminergic receptors upon local cerebral blood flow.
    Teasdale G; McCulloch J
    Acta Neurol Scand Suppl; 1977; 64():98-9. PubMed ID: 409089
    [No Abstract]   [Full Text] [Related]  

  • 2. Dopaminergic systems and the cerebral circulation.
    McCulloch J; Harper AM
    Acta Neurol Scand Suppl; 1977; 64():100-1. PubMed ID: 409056
    [No Abstract]   [Full Text] [Related]  

  • 3. Cerebral circulation: effect of stimulation and blockade of dopamine receptors.
    McCulloch J; Harper AM
    Am J Physiol; 1977 Aug; 233(2):H222-7. PubMed ID: 407806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopaminergic influence upon the cerebral circulation in the anaesthetized baboon [proceedings].
    Harper AM; McCulloch J
    J Physiol; 1977 Feb; 265(1):24P-25P. PubMed ID: 850167
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of apomorphine upon local cerebral blood flow.
    McCulloch J; Teasdale G
    Eur J Pharmacol; 1979 Apr; 55(1):99-102. PubMed ID: 108114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral circulatory effects of a dopaminergic agonist (apomorphine) in the dog.
    Jauzac P; Blasco A; Vigoni F; Valdiguie P; Bès A
    J Cereb Blood Flow Metab; 1982 Sep; 2(3):369-72. PubMed ID: 7096461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous study of learning, cerebral hemodynamics, and metabolism in aged rats: effects of a dopaminergic agonist.
    Le Poncin-Lafitte M; Lamproglou Y; Duterte D; Rapin JR
    Monogr Neural Sci; 1984; 11():68-77. PubMed ID: 6738562
    [No Abstract]   [Full Text] [Related]  

  • 8. Relief of akinesia by apomorphine and cerebral metabolic changes in Parkinson's disease.
    Broussolle E; Cinotti L; Pollak P; Landais P; Le Bars D; Galy G; Lavenne F; Khalfallah Y; Chazot G; Mauguière F
    Mov Disord; 1993 Oct; 8(4):459-62. PubMed ID: 8232355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apomorphine as a preferential stimulant of self-inhibitory dopamine receptors in man.
    Corsini GU; Del Zompo M; Piccardi MP; Mangoni A; Gessa GL
    Ann Ist Super Sanita; 1978; 14(1):123-30. PubMed ID: 756167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of apomorphine on the relationship between local cerebral glucose utilization and local cerebral blood flow (with an appendix on its statistical analysis).
    McCulloch J; Kelly PA; Ford I
    J Cereb Blood Flow Metab; 1982 Dec; 2(4):487-99. PubMed ID: 7142312
    [No Abstract]   [Full Text] [Related]  

  • 11. Detection of the effects of dopamine receptor supersensitivity using pharmacological MRI and correlations with PET.
    Nguyen TV; Brownell AL; Iris Chen YC; Livni E; Coyle JT; Rosen BR; Cavagna F; Jenkins BG
    Synapse; 2000 Apr; 36(1):57-65. PubMed ID: 10700026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-inhibitory dopamine-receptors and central effects of apomorphine.
    Di Chiara G; Porceddu ML; Morelli M; Gessa GL
    Ann Ist Super Sanita; 1978; 14(1):111-22. PubMed ID: 756166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of the dopaminergic component in the autoregulatory reaction of the cerebral vessels].
    Gaevyĭ MD; Pchelintseva TR; Vereshchagin VK; Migruev RR
    Fiziol Zh SSSR Im I M Sechenova; 1989 Jun; 75(6):793-7. PubMed ID: 2806646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Characteristics of "behavior modification" induced by dopaminergic stimulation].
    Costentin J; Baudry M; Marcais H; Martres MP; Protais P
    Arch Farmacol Toxicol; 1978 Apr; 4(1):64-5. PubMed ID: 29573
    [No Abstract]   [Full Text] [Related]  

  • 15. Dopamine D1 and D2 receptors are sensitive to the cationic form of apomorphine.
    Seeman P; Guan HC
    Mol Pharmacol; 1987 Dec; 32(6):760-3. PubMed ID: 2961976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation of the central dopaminergic stimulants apomorphine and lergotrile.
    Wade RL; Krewsun I; Quock RM
    Proc West Pharmacol Soc; 1979; 22():141-2. PubMed ID: 42079
    [No Abstract]   [Full Text] [Related]  

  • 17. Pre- and post-synaptic dopaminergic receptors involved in apomorphine-induced yawning.
    Urba-Holmgren R; Holmgren B; Anias J
    Acta Neurobiol Exp (Wars); 1982; 42(2):115-25. PubMed ID: 6891988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropsychiatric implications of drugs acting on dopamine receptors: the effect of apomorphine.
    Corsini GU; Bernardi F; Marrosu F; Gessa GL
    Prog Clin Biol Res; 1980; 39():225-37. PubMed ID: 6447296
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of apomorphine and haloperidol on plasma cortisol levels in conscious dogs.
    Uvnäs-Wallensten K; Goiny M; Oriowo MA; Cekan S
    Acta Physiol Scand; 1981 Jul; 112(3):253-6. PubMed ID: 7293796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of dopamine receptor blockade on cerebral blood flow response to somatosensory stimulation in the unanesthetized rat.
    Esaki T; Itoh Y; Shimoji K; Cook M; Jehle J; Sokoloff L
    J Pharmacol Exp Ther; 2002 Nov; 303(2):497-502. PubMed ID: 12388628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.